Aurora Cannabis said fiscal 2026 performance came in above its forecast, helped by growth in global medical cannabis. However, management warned fiscal 2027 will be a "reset year" as Canadian medical reimbursement dynamics change, signaling near-term headwinds despite the stronger recent results.
Aurora Cannabis said fiscal 2026 performance came in above its forecast, helped by growth in global medical cannabis. However, management warned fiscal 2027 will be a "reset year" as Canadian medical reimbursement dynamics change, signaling near-term headwinds despite the stronger recent results.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
neutral
Sentiment Score
0.15
Ticker Sentiment
